Qinghua Wang

Qinghua Wang is the founder of Innogen Pharmaceutical. Innogen Pharmaceutical has raised $206M in total funding. Latest round: IPO.

About Qinghua Wang

Qinghua Wang is the CEO of Innogen Pharmaceutical Technology, a Chinese biotech company that develops drugs for diabetes and metabolic disorders. The company secured $120 million in funding to advance its drug development and venture into manufacturing. Innogen Pharmaceutical also announced an $86 million IPO on the Hong Kong Stock Exchange to advance its lead product, Diabegone (efsubaglutide alfa).

Qinghua Wang at a glance

More founder profiles (44)

Browse related founder lists (1)

Full founder directory · Investor directory · Company funding database · Fundraising library